Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for MTD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -1.942M
March 31, 2026 -31.35M
December 31, 2025 -40.40M
September 30, 2025 -98.91M
June 30, 2025 -47.65M
March 31, 2025 -6.907M
December 31, 2024 -51.05M
September 30, 2024 -37.64M
June 30, 2024 -21.83M
March 31, 2024 -8.935M
December 31, 2023 -35.50M
September 30, 2023 -30.90M
June 30, 2023 -42.91M
March 31, 2023 -22.39M
December 31, 2022 -50.04M
September 30, 2022 -48.70M
June 30, 2022 -33.54M
March 31, 2022 -7.112M
December 31, 2021 -62.88M
September 30, 2021 -25.18M
June 30, 2021 -34.59M
March 31, 2021 -191.45M
December 31, 2020 -30.32M
September 30, 2020 -19.46M
June 30, 2020 -16.13M
Date Value
March 31, 2020 -34.45M
December 31, 2019 -22.60M
September 30, 2019 -31.27M
June 30, 2019 -27.68M
March 31, 2019 -17.53M
December 31, 2018 -44.35M
September 30, 2018 -44.08M
June 30, 2018 -28.05M
March 31, 2018 -22.46M
December 31, 2017 -37.23M
September 30, 2017 -140.07M
June 30, 2017 -29.35M
March 31, 2017 -10.70M
December 31, 2016 -72.93M
September 30, 2016 -126.63M
June 30, 2016 -15.48M
March 31, 2016 -16.41M
December 31, 2015 -27.74M
September 30, 2015 -24.10M
June 30, 2015 -21.83M
March 31, 2015 -27.08M
December 31, 2014 -30.08M
September 30, 2014 -24.28M
June 30, 2014 -23.16M
March 31, 2014 -16.92M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Waters Corp. 2.00M
Agilent Technologies, Inc. -1.032B
Bio-Rad Laboratories, Inc. -66.70M
Danaher Corp. -10.15B
Revvity, Inc. -3.505M